| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 19 | 0 | 1992 | 2020 | ||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
disease | 0.500 | None | 0.982 | 7 | 0 | 2003 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 3 | 0 | 1994 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2009 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.440 | None | 1.000 | 1 | 0 | 1999 | 2010 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.877 | 7 | 0 | 1994 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.400 | None | 0.912 | 6 | 0 | 1991 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.970 | 4 | 0 | 1994 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.922 | 4 | 0 | 1996 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.400 | None | 0.846 | 3 | 0 | 1994 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.400 | None | 0.986 | 1 | 0 | 1999 | 2020 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.891 | 1 | 0 | 1999 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 0.722 | 1 | 0 | 1997 | 2015 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.905 | 1 | 0 | 1997 | 2019 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
disease | 0.360 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.350 | None | 0.667 | 1 | 0 | 2001 | 2010 | ||||||||
|
nectin cell adhesion molecule 2 | 0.575 | 0.769 | 0.97 |
|
disease | 0.330 | None | 0.667 | 1 | 0 | 2004 | 2007 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.880 | 8 | 0 | 1990 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.884 | 2 | 0 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 1 | 0 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1979 | 2019 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.180 | None | 0.889 | 1 | 0 | 2007 | 2017 | ||||||||
|
CD226 molecule | 0.548 | 0.769 | 3.9E-02 |
|
disease | 0.180 | None | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
glypican 5 | 0.626 | 0.654 | 4.0E-10 |
|
disease | 0.170 | None | 1.000 | 1 | 0 | 2009 | 2014 | ||||||||
|
ecotropic viral integration site 5 | 0.743 | 0.346 | 2.0E-11 |
|
disease | 0.160 | None | 1.000 | 1 | 0 | 2008 | 2017 |